Danielle Schlosser
Overview
Explore the profile of Danielle Schlosser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
318
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fisher M, Etter K, Murray A, Ghiasi N, LaCross K, Ramsay I, et al.
J Med Internet Res
. 2023 Nov;
25:e48634.
PMID: 37955951
Background: Impairments in cognition and motivation are core features of psychosis and strong predictors of social and occupational functioning. Accumulating evidence indicates that cognitive deficits in psychosis can be improved...
2.
Dougherty R, Clarke P, Atli M, Kuc J, Schlosser D, Dunlop B, et al.
Psychopharmacology (Berl)
. 2023 Aug;
PMID: 37606733
Rationale: Therapeutic administration of psychedelics has shown significant potential in historical accounts and recent clinical trials in the treatment of depression and other mood disorders. A recent randomized double-blind phase-IIb...
3.
Modlin N, Miller T, Rucker J, Kirlic N, Lennard-Jones M, Schlosser D, et al.
J Affect Disord
. 2023 Jan;
326:18-25.
PMID: 36707036
Recent studies have demonstrated the promise of psilocybin therapies in creating positive changes for those with poor mental health across multiple diagnostic categories, including major depressive disorder (MDD), end-of-life anxiety,...
4.
Loewy R, Fisher M, Ma S, Carter C, Ragland J, Niendam T, et al.
Schizophr Bull
. 2021 Sep;
48(1):262-272.
PMID: 34510196
Objective: Cognitive impairment in schizophrenia predicts functional outcomes and is largely unresponsive to pharmacology or psychotherapy; it is thus a critical unmet treatment need. This article presents the impact of...
5.
Seabury S, Axeen S, Pauley G, Tysinger B, Schlosser D, Hernandez J, et al.
Health Aff (Millwood)
. 2019 Apr;
38(4):652-659.
PMID: 30933598
Serious mental illness (SMI) is a disabling condition that develops early in life and imposes substantial economic burden. There is a growing belief that early intervention for SMI has lifelong...
6.
Biagianti B, Fisher M, Brandrett B, Schlosser D, Loewy R, Nahum M, et al.
Schizophr Res
. 2019 Feb;
208:250-257.
PMID: 30733167
Cognitive impairment in schizophrenia is often severe, enduring, and contributes significantly to chronic disability. A standardized platform for identifying cognitive impairments and measuring treatment effects in cognition is a critical...
7.
Loewy R, Corey S, Amirfathi F, Dabit S, Fulford D, Pearson R, et al.
Schizophr Res
. 2018 May;
205:10-14.
PMID: 29779964
As a risk factor for psychosis, childhood trauma rates are elevated in the clinical-high-risk (CHR) syndrome compared to the general population. However, it is unknown whether trauma is typically experienced...
8.
Baumel A, Baker J, Birnbaum M, Christensen H, De Choudhury M, Mohr D, et al.
Psychiatr Serv
. 2018 Jan;
69(5):590-592.
PMID: 29334875
Technology provides an unparalleled opportunity to remove barriers to earlier identification and engagement in services for mental and addictive disorders by reaching people earlier in the course of illness and...
9.
Biagianti B, Schlosser D, Nahum M, Woolley J, Vinogradov S
JMIR Ment Health
. 2016 Dec;
3(4):e52.
PMID: 27965190
Background: Numerous psychosocial interventions for individuals with chronic psychotic disorders (CPD) have shown positive effects on social cognitive and functional outcome measures. However, access to and engagement with these interventions...
10.
Schlosser D, Campellone T, Kim D, Truong B, Vergani S, Ward C, et al.
JMIR Res Protoc
. 2016 Apr;
5(2):e77.
PMID: 27125771
Background: Despite improvements in treating psychosis, schizophrenia remains a chronic and debilitating disorder that affects approximately 1% of the US population and costs society more than depression, dementia, and other...